Marks, D I <br/><br/>
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.  [electronic resource] 

 -  British journal of haematology  Jul 1992 
 - 383-90 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.1992.tb08244.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Marrow Transplantation--immunology<br/>Child<br/>Cyclosporine--therapeutic use<br/>DNA, Neoplasm--genetics<br/>Drug Therapy, Combination<br/>Female<br/>Fusion Proteins, bcr-abl--genetics<br/>Graft vs Host Disease--immunology<br/>HLA Antigens--immunology<br/>Histocompatibility--immunology<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Prognosis<br/>RNA, Messenger--analysis<br/>Recurrence<br/>Transcription, Genetic--genetics